Join to View Full Profile
300 Longwood AveBader 7Boston, MA 02115
Phone+1 617-355-6347
Dr. Platt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1978 - 1979
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1975 - 1978
Mass General Brigham/Massachusetts General HospitalResidency, Pediatrics, 1973 - 1975
Harvard Medical SchoolClass of 1973
Certifications & Licensure
MA State Medical License 1975 - 2025
American Board of Pediatrics Pediatrics
Publications & Presentations
PubMed
- 5 citationsHeritability of fetal hemoglobin, white cell count, and other clinical traits from a sickle cell disease family cohort.Erik L. Bao, Caleb A. Lareau, Carlo Brugnara, Isabel R. Fulcher, Caroline Barau
American Journal of Hematology. 2019-02-06 - 293 citationsMirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locusSébastien Jacquemont, Alexandre Reymond, Flore Zufferey, Louise Harewood, Robin G. Walters
Nature. 2011-10-06 - 16 citationsAge- and gender-dependent obesity in individuals with 16p11.2 deletion.Yongguo Yu, Haitao Zhu, David T. Miller, James F. Gusella, Orah S. Platt
Journal of Genetics and Genomics = Yi Chuan Xue Bao. 2011-09-20
Press Mentions
Sickle Cell Gene Therapy and Boosting Fetal Hemoglobin: A 75-Year HistoryDecember 12th, 2023
Grant Support
- Genetic Modifiers Of Severity In Sickle Cell DiseaseNational Center For Research Resources2004–2008
- Genetic Modifiers Of Severity In Sickle Cell AnemiaNational Heart, Lung, And Blood Institute2001–2005
- Red Blood Cell PhysiologyNational Heart, Lung, And Blood Institute1998–2002
- Hydroxyurea For Treatment Of Children With Sickle Cell AnemiaNational Center For Research Resources1996–2000
- Pathophysiology Of Red Cell Membranes In Sickle Cell DiseaseNational Heart, Lung, And Blood Institute1993–1997
- Use Of Hydroxyurea In Sickle Cell AnemiaNational Heart, Lung, And Blood Institute1987–1989
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
